MedTrace Logo

Comparing Pregabalin and Placebo in Patients With Persistent Globus Sensation

NCT05432843 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 90

Last updated 2022-07-06

No results posted yet for this study

Summary

To evaluate the relative merits, safety and effectiveness of pregabalin in globus patients compared with placebo.

Conditions

  • Globus Sensation

Interventions

DRUG

Pregabalin

Patients receive for one week Pregabalin 75 mg and 7 weeks Pregabalin 150 mg

DRUG

Placebo

Patients receive a treatment with placebo for 8 weeks

Sponsors & Collaborators

  • Universitaire Ziekenhuizen KU Leuven

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-12
Primary Completion
2023-01-31
Completion
2023-01-31

Countries

  • Belgium

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05432843 on ClinicalTrials.gov